Infectious Disease Control
Starpharma signs distribution agreement for VIRALEZE™ antiviral nasal spray in Vietnam
* Starpharma has signed a 5-year supply and distribution agreement for VIRALEZE™ inVietnam * The agreement includes a minimum commitment of 1 million units in the first year * VIRALEZE™ is scheduled to be officially launched in Vietnam today, following its registration for sale this week ...
2021-12-03 14:24
3585
CGTN: Peng Liyuan sends message to Linfen Red Ribbon School students on World AIDS Day
BEIJING, Dec. 2, 2021 /PRNewswire/ -- Peng Liyuan, wife of Chinese President Xi Jinping and the World Health Organization (WHO)'s goodwill ambassador for tuberculosis and HIV/AIDS, sent a video message to the students of the Linfen Red Ribbon School in northChina's Shanxi Province at an event mar...
2021-12-02 13:03
5066
Cue Health Receives Singapore HSA Authorization for its Molecular COVID-19 Test for Self-Testing
- The Cue COVID-19 Test was authorized for self-testing by the Singapore Health Sciences Authority (HSA) through its Pandemic Special Access Route (PSAR) - The HSA authorization of the Cue COVID-19 Test is for home use in both symptomatic and asymptomatic users, ages 2 years and up - Cue Health ...
2021-12-02 02:28
2241
World Federation of Neurology Impresses Importance of Brain Health Through Global Public Initiative
LONDON, Dec. 1, 2021 /PRNewswire/ -- The World Federation of Neurology (WFN) is leading the charge on advocating for brain health awareness, through the launch of its Brain Health Initiative (BHI), a program created to reduce the immense global burden of brain diseases and disorders. Neurological...
2021-12-01 16:22
2533
EpiVax Progresses on a Vaccine to Address SARS-CoV-2 Variants
PROVIDENCE, R.I., Dec. 1, 2021 /PRNewswire/ -- Today EpiVax, Inc. ("EpiVax") confirmed that the company'sEPV-CoV-19 vaccine epitopes are 98.2% conserved in the new Omicron SARS-CoV-2 variant. EpiVax and EpiVax Therapeutics, Inc. ("EVT") are also affirming commitment to move the novel T cell epito...
2021-12-01 05:22
2910
New CELLSEARCH® Circulating Multiple Myeloma Test now available to help community physicians optimize patient care
As the market leader in cell-based liquid biopsies, Menarini Silicon Biosystems is offering community hematology-oncologists an opportunity to have patient blood samples sent to a US centralized laboratory where itsCELLSEARCH® technology can enumerateCirculating Multiple Myeloma Cells (CMMCs) f...
2021-11-30 22:18
3592
Seegene's High Multiplex PCR Assay Capable of Detecting New Omicron Variant
SEOUL, South Korea, Nov. 30, 2021 /PRNewswire/ -- Seegene Inc. (KQ 096530), South Korea's leading molecular diagnostics company, today confirmed that its Allplex™ SARS-CoV-2 Master Assay is capable of detecting the Omicron's unique pattern of mutations. The well-established PCR-based test recogni...
2021-11-30 19:25
3496
JOYSBIO's SARS-COV-2 Antigen Rapid test detects OMICRON variant
TIANJIN, China, Nov. 30, 2021 /PRNewswire/ -- JOYSBIO, one of the world's leading manufacturers of lateral flow rapid tests, is proud to announce that their tests are available around the world. Furthermore, they've been able to show that their test can detect the new Omicron (B.1.1.529). This va...
2021-11-30 14:00
3358
CGTN: China-Africa friendship continues to flourish on vaccine, trade, renewable energy
BEIJING, Nov. 30, 2021 /PRNewswire/ -- China-Africa friendship is expected to continue to flourish as cooperation is further deepened in various areas after the ongoing 8th Ministerial Conference of the Forum on China-Africa Cooperation (FOCAC) held inDakar, Senegal.   China wi...
2021-11-30 10:03
4377
Innovative €250,000 Parenteral Nutrition Research Grant Awarded by Fresenius Kabi
BAD HOMBURG, Germany, Nov. 25, 2021 /PRNewswire/ -- Fresenius Kabi was delighted to announce the winner of their innovative JUMPstart education program and research grant onSeptember 10, 2021. JUMPstart is an initiative that aims to nurture research in the field of parenteral nutrition through th...
2021-11-25 15:45
4802
Novavax Files for Interim Authorization of COVID-19 Vaccine in Singapore
GAITHERSBURG, Md., Nov. 24, 2021 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced its submission to the Singapore Health Sciences Authority (HSA) for interim ...
2021-11-24 22:15
3425
Global COVID-19 Safety Innovator Expands Its Offerings
"Investing smartly in the safety of employees." Including, now, a US OSHA COVID-Rules-Compliant SaaS Platform Enhancement BOSTON, Nov. 24, 2021 /PRNewswire/ -- Safely2Prosperity LLC CEO John Norris, JD, MBA, announces S2P's new COVID-19 Safety Platform and Employee Dashboard for quick demonstrat...
2021-11-24 11:42
5912
Laos becomes the 20th country to authorize the one-shot Sputnik Light vaccine
MOSCOW, Nov. 24, 2021 /PRNewswire/ -- The Russian Direct Investment Fund (RDIF, Russia's sovereign wealth fund) today announced the Russian single-component Sputnik Light vaccine against coronavirus has been approved in Lao People's Democratic Republic. ThusLaos has become the 20th country to ...
2021-11-24 07:47
2117
Seegene Announces Q3 2021 Earnings, Continuing COVID-Era Momentum
* Q3 Revenue held steady at KRW 305.3 billion * Operating profit dipped slight due to powerful investment in R&D * Scheduled to introduce new diagnostic tests capable of screening 22 targets, including3 genes of COVID-19 and 19 respiratory viruses in a single tube SEOUL, South Korea, Nov. 2...
2021-11-23 16:03
2570
SyneuRx Announces Oral COVID-19 Twindemic Antiviral Drug Candidate Pentarlandir Has Entered Final Portion of FDA Phase II Testing
Based on Highly-Purified Isomers of Tannic Acid and Acting as a Dual Protease and TMPRSS2 Inhibitor, Pentarlandir Has Shown Significant Anti-Viral Properties with Minimal Observed Side Effects NEW TAIPEI CITY, Taiwan and TORRANCE, Calif., Nov. 20, 2021 /PRNewswire/ -- SyneuRx™ International, (Ta...
2021-11-20 01:00
3998
Brii Biosciences Joins Hang Seng Composite Index
DURHAM, N.C. and BEIJING, Nov. 19, 2021 /PRNewswire/ -- Brii Biosciences
2021-11-19 19:06
4740
Experts warn that post-COVID hygiene lethargy could put millions at risk of fatal infections due to antimicrobial resistance
LONDON, Nov. 19, 2021 /PRNewswire/ -- With over 5 million deaths worldwide, COVID-19 has imposed a significant burden on societies and healthcare systems around the world. As we continue to address the impact of COVID-19, there is an even greater public health threat which must be tackled, AMR. T...
2021-11-19 15:01
3566
Novavax Confirms European Medicines Agency Review of COVID-19 Vaccine Filing for Conditional Marketing Authorization
GAITHERSBURG, Md., Nov. 18, 2021 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced that European Medicines Agency (EMA) has begun its evaluation of an applicat...
2021-11-18 06:52
4079
Novavax and Serum Institute of India Receive Emergency Use Authorization for COVID-19 Vaccine in the Philippines
GAITHERSBURG, Md. and PUNE, India, Nov. 17, 2021 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, and Serum Institute of India Pvt. Ltd. (SII), the world's largest vaccine m...
2021-11-17 23:23
4867
Brii Bio Receives the BioCentury-BayHelix R&D Achievement of the Year Award at the 2021 BioCentury China Healthcare Summit
BEIJING and DURHAM, N.C., Nov. 17, 2021 /PRNewswire/ -- Brii Biosciences Limited
2021-11-17 18:52
5158
Week's Top Stories
Most Reposted
SMU School of Accountancy launches Applied AI Track for next generation of accounting and finance professionals
[Picked up by 282 media titles]
2026-10-07 11:50DayOne Files Registration Statement for Proposed Initial Public Offering
[Picked up by 279 media titles]
2026-10-06 05:28Agoda Partners with Marina Bay Sands on Bespoke Flagship Store for Experience-Led Travel
[Picked up by 277 media titles]
2026-10-08 09:50
New Asia Forum Targets US$30 Billion in Investment into the New Asia at Its Inaugural Edition in Bali
[Picked up by 275 media titles]
2026-10-09 13:21CHANDO Group Presents 20 Research Papers at IFSCC 2026 Congress in Perth
[Picked up by 263 media titles]
2026-10-06 11:40
Most Read
DayOne Files Registration Statement for Proposed Initial Public Offering
2026-10-06 05:28
10084
Nuix Neo Generative AI Framework
2026-10-08 08:02
10048
Silicon Quantum Computing Named to Fast Company's 2026 Next Big Things in Tech List
2026-10-06 19:38
9196
